Immunocore Holdings Plc Adr (IMCR)

Mar 09, 2026

Immunocore at Leerink Conference: Strategic Growth and Innovation - Investing.com

Mar 09, 2026

Mar 07, 2026

Q1 Earnings Forecast for Immunocore Issued By HC Wainwright - Defense World

Mar 07, 2026

Mar 06, 2026

What is HC Wainwright's Estimate for Immunocore Q1 Earnings? - MarketBeat

Mar 06, 2026

Mar 06, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 06, 2026

Mar 05, 2026

FY2027 EPS Estimates for Immunocore Cut by HC Wainwright - MarketBeat

Mar 05, 2026

Mar 03, 2026

Immunocore to present at upcoming investor conferences - GlobeNewswire Inc.

Mar 03, 2026

Feb 27, 2026

Immunocore (NASDAQ:IMCR) Price Target Raised to $75.00 at Needham & Company LLC - Defense World

Feb 27, 2026

Feb 25, 2026

Immunocore Q4 Earnings Call Highlights - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates - Investing.com South Africa

Feb 25, 2026

Feb 25, 2026

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz

Feb 25, 2026

Feb 25, 2026

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations - Finviz

Feb 25, 2026

Feb 25, 2026

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz

Feb 25, 2026

Feb 25, 2026

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y - Finviz

Feb 25, 2026

Feb 25, 2026

Earnings call transcript: Immunocore Holdings Q4 2025 reveals strong growth, stock dips By Investing.com - Investing.com South Africa

Feb 25, 2026

Feb 25, 2026

Earnings call transcript: Immunocore Holdings Q4 2025 reveals strong growth, stock dips - Investing.com India

Feb 25, 2026

Feb 24, 2026

Immunocore earnings ahead as melanoma pipeline advances By Investing.com - Investing.com India

Feb 24, 2026

Feb 24, 2026

Immunocore earnings ahead as melanoma pipeline advances - Investing.com

Feb 24, 2026

Feb 20, 2026

Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down - Finviz

Feb 20, 2026

Feb 19, 2026

Immunocore (NASDAQ:IMCR) CAO John Goll Sells 698 Shares - MarketBeat

Feb 19, 2026

Feb 19, 2026

Leger Tina Amber St Sells 1,000 Shares of Immunocore (NASDAQ:IMCR) Stock - MarketBeat

Feb 19, 2026

Feb 19, 2026

Immunocore (NASDAQ:IMCR) CEO Bahija Jallal Sells 11,474 Shares - MarketBeat

Feb 19, 2026

Feb 19, 2026

David Berman Sells 5,965 Shares of Immunocore (NASDAQ:IMCR) Stock - MarketBeat

Feb 19, 2026

Feb 18, 2026

[144] Immunocore Holdings plc SEC Filing - Stock Titan

Feb 18, 2026

Feb 17, 2026

Immunocore (IMCR) upgraded to strong buy: Here's why - MSN

Feb 17, 2026

Feb 17, 2026

Immunocore (IMCR) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Feb 17, 2026

Feb 13, 2026

SNY Stock Falls After Board Suddenly Makes Leadership Change - Finviz

Feb 13, 2026

Feb 11, 2026

Immunocore Holdings PLC Sponsored ADR $IMCR Stock Holdings Lifted by Candriam S.C.A. - MarketBeat

Feb 11, 2026

Feb 10, 2026

Immunocore Holdings PLC Sponsored ADR $IMCR Shares Sold by Principal Financial Group Inc. - MarketBeat

Feb 10, 2026

Feb 09, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 09, 2026

Feb 06, 2026

GSK Gets EU Approval for Expanded Use of Nucala in COPD - Finviz

Feb 06, 2026

Feb 06, 2026

HC Wainwright Weighs in on Immunocore FY2030 Earnings - Defense World

Feb 06, 2026

Feb 05, 2026

Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates - Finviz

Feb 05, 2026

Feb 05, 2026

HC Wainwright Predicts Immunocore FY2030 Earnings - MarketBeat

Feb 05, 2026

Feb 04, 2026

NVO Q4 Earnings & Sales Beat Estimates, Stock Down on Poor 2026 View - Finviz

Feb 04, 2026

Feb 03, 2026

Acadia Expects Negative CHMP Opinion for Rett Syndrome Drug in EU - The Globe and Mail

Feb 03, 2026

Feb 03, 2026

NVO's CagriSema Outshines Semaglutide in Phase III Diabetes Study - Finviz

Feb 03, 2026

Jan 30, 2026

Immunocore Holdings (IMCR) is One of the Best Small Cap Stocks Ready to Explode in 2026 - Finviz

Jan 30, 2026

Jan 30, 2026

Immunocore announces resignation of head of research and development By Investing.com - Investing.com South Africa

Jan 30, 2026

Jan 30, 2026

Immunocore announces resignation of head of research and development - Investing.com

Jan 30, 2026

Jan 30, 2026

Immunocore announces executive leadership changes in R&D - Investing.com

Jan 30, 2026

Jan 29, 2026

TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth - Finviz

Jan 29, 2026

Jan 28, 2026

Immunocore Holdings plc Share Price ADS Each Rep 1 Ord Share SPON - Hargreaves Lansdown

Jan 28, 2026

Jan 27, 2026

BHC's Late-Stage Liver Cirrhosis Studies Fail, Stock Down - The Globe and Mail

Jan 27, 2026

Jan 23, 2026

CORT Rises as Relacorilant Meets OS Endpoint in Ovarian Cancer Study - Finviz

Jan 23, 2026

Jan 22, 2026

MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data - sharewise.com

Jan 22, 2026

Jan 22, 2026

Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Jan 22, 2026

Jan 21, 2026

FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate - Finviz

Jan 21, 2026

Jan 15, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Jan 15, 2026